| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/1993 | CA2090635A1 Substituted phenylquinazoline derivatives |
| 09/03/1993 | CA2090535A1 Dioxolane derivatives |
| 09/02/1993 | WO1993017043A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | WO1993017036A1 Alkali metal 8,9-dehydroestrone sulfate esters |
| 09/02/1993 | WO1993017033A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | WO1993017028A1 Sensitizing agents for use in boron neutron capture therapy |
| 09/02/1993 | WO1993017027A1 Novel therapeutical use of pyridylpyrrolothiazole carboxamide derivatives |
| 09/02/1993 | WO1993017025A1 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity |
| 09/02/1993 | WO1993017024A1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists |
| 09/02/1993 | WO1993017023A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists |
| 09/02/1993 | WO1993017021A1 Heterocyclic compounds for enhancing antitumor activity |
| 09/02/1993 | WO1993017020A2 Therapeutic nucleosides |
| 09/02/1993 | WO1993017019A1 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist |
| 09/02/1993 | WO1993017018A1 Nitrosation process |
| 09/02/1993 | WO1993017017A1 [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
| 09/02/1993 | WO1993017014A1 Indole derivatives as steroid 5 alpha-reductase inhibitors |
| 09/02/1993 | WO1993017013A1 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 09/02/1993 | WO1993017012A1 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
| 09/02/1993 | WO1993017008A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO[b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
| 09/02/1993 | WO1993017007A1 Heterobicyclic compounds |
| 09/02/1993 | WO1993017006A1 N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 09/02/1993 | WO1993017004A1 Benzisoxazole derivatives and pharmaceutical compositions containing them |
| 09/02/1993 | WO1993017003A1 Retroviral protease inhibitors |
| 09/02/1993 | WO1993016999A1 Benzodiazepin derivatives useful as cck-receptor antagonists |
| 09/02/1993 | WO1993016997A1 2,3,4,5-TETRAHYDRO-1H^_-3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF α-SUBSTITUTED-ARYLACETAMIDES |
| 09/02/1993 | WO1993016996A1 Indole derivatives as testosterone-5-alpha-reductase inhibitors |
| 09/02/1993 | WO1993016995A1 Process for preparing fibrinogen receptor antagonists |
| 09/02/1993 | WO1993016993A1 Antioxidant diaryl tellurides |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | WO1993016980A1 Cholesterol lowering compounds |
| 09/02/1993 | WO1993016978A1 Ketotricyclo(5.2.1.0)decane derivates |
| 09/02/1993 | WO1993016737A1 Biodegradable germicide |
| 09/02/1993 | WO1993016733A1 Topical composition containing hyaluronic acid and nsaids |
| 09/02/1993 | WO1993016732A1 Formulations containing hyaluronic acid |
| 09/02/1993 | WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 09/02/1993 | WO1993016720A1 Inhibition of bacterial endotoxin |
| 09/02/1993 | WO1993016711A1 Use of injectable biomaterials in the treatment of hemorrhoids |
| 09/02/1993 | WO1993016708A1 Pharmaceutical compositions and their use for treating zinc deficient disorders |
| 09/02/1993 | WO1993016707A1 Linseed mucilage |
| 09/02/1993 | WO1993016706A1 Use of substituted adenine derivatives for treating multiple sclerosis |
| 09/02/1993 | WO1993016705A1 A pharmaceutical composition with improved bioavailability of inositol phosphate |
| 09/02/1993 | WO1993016704A1 Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof |
| 09/02/1993 | WO1993016703A1 Protein kinase c inhibitor |
| 09/02/1993 | WO1993016702A1 Quinobenzoxazine, quinobenzothiazine, and pyrido-acridine antineoplastic agents |
| 09/02/1993 | WO1993016701A2 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 09/02/1993 | WO1993016700A1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and ×dema |
| 09/02/1993 | WO1993016699A1 Tnf inhibitors |
| 09/02/1993 | WO1993016696A1 Brofaromine as an agent for treating social phobia |
| 09/02/1993 | WO1993016695A1 Brofaromine as an agent for treating post-traumatic stress |
| 09/02/1993 | WO1993016694A1 Use of indylpyridylureas to heal the effects of brain or spiral trauma |
| 09/02/1993 | WO1993016693A1 Novel and prior art disulphides and their use in the control of helicobacter bacteria |
| 09/02/1993 | WO1993016691A1 New use of omega-3-fatty acids |
| 09/02/1993 | WO1993016690A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | WO1993016689A1 Pharmaceutical composition for use as a pain killer and containing (benzoyl-3 phenyl)-2 propionic-(r) acid |
| 09/02/1993 | WO1993016688A1 Facilitated oxygen delivery in conjunction with hemodilution |
| 09/02/1993 | WO1993016686A1 Pharmaceutical preparation for sustained release of a drug and process for producing the same |
| 09/02/1993 | WO1993016674A1 CoA-IT AND PAF INHIBITORS |
| 09/02/1993 | WO1993016658A1 Use of injectable biomaterials for the repair and augmentation of the anal sphincters |
| 09/02/1993 | WO1993016602A1 Animal feedstuff for growth increase |
| 09/02/1993 | WO1993016598A1 Effect of particle-size distribution of cellulose ethers on palatability of compositions |
| 09/02/1993 | WO1993016595A1 Nutritional product for trauma and surgery patients |
| 09/02/1993 | WO1993015112A3 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 09/02/1993 | WO1993014767A3 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 09/02/1993 | WO1993014760A3 Methods |
| 09/02/1993 | WO1993013740A3 Antiparasitic oligonucleotides active against drug resistant malaria |
| 09/02/1993 | WO1993010141A3 Angiostatic steroids |
| 09/02/1993 | DE4206375A1 Medicaments for treating Alzheimer's disease - contg. Phytolacca dodecandra glycoside(s), reduce aluminium levels in brain |
| 09/02/1993 | DE4205843A1 Medical use of 1-methyl-4-piperidyl di:phenyl-acetate - for prodn. of medicament for treating hypertonic bladder dysfunction |
| 09/02/1993 | DE4201148A1 Medical use of thieno:triazolo:diazepine derivs. - for prophylaxis or therapy of allergic rhinitis or conjunctivitis |
| 09/02/1993 | CA2130993A1 Use of injectable biomaterials in the treatment of hemorrhoids |
| 09/02/1993 | CA2130802A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | CA2130443A1 Pharmaceutical compositions and their use for treating zinc deficient disorders |
| 09/02/1993 | CA2130350A1 Linseed mucilage |
| 09/02/1993 | CA2129987A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | CA2129732A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | CA2129337A1 Heterocyclic compounds for enhancing antitumor activity |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | CA2128871A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists |
| 09/02/1993 | CA2128701A1 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo¬b|-thiophene-2-carboxamides as inhibitors of cell adhesion |
| 09/02/1993 | CA2127545A1 New therapeutic application for pyridyl pyrrolo thiazole carboxamide derivatives |
| 09/02/1993 | CA2117535A1 New use of omega-3-fatty acids |
| 09/02/1993 | CA2117430A1 Brofaromine as an agent for treating post-traumatic stress |
| 09/02/1993 | CA2117381A1 N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea compounds having lipoxygenase inhibitory activity |
| 09/01/1993 | EP0558468A1 Medicament for inhibiting nitric oxide formation |
| 09/01/1993 | EP0558449A1 Complexes of chelating ligands and process for their preparation |
| 09/01/1993 | EP0558443A1 O-Piperidyl-(3/4)-hydroxylamines and O-piperidyl-(3/4)-alkyl-hydroxylamines and their use as ornithine decarboxylase inhibitors |
| 09/01/1993 | EP0558435A1 Sulfated diosmin derivative |
| 09/01/1993 | EP0558416A1 New 17-(methylene)-lactone spiro condensed steroids, method and intermediates for their production, their use as medicines and pharmaceutical compositions containing them |
| 09/01/1993 | EP0558321A1 Antivirally active N-cycloalkyl alkanol compounds |
| 09/01/1993 | EP0558287A1 Tetrahydrothiophene derivatives |
| 09/01/1993 | EP0558258A1 N-isoxazole-naphthylsulfonamide derivatives and their use as endothelin antagonists |
| 09/01/1993 | EP0558245A1 Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors |
| 09/01/1993 | EP0558215A1 Novel methods and compounds for the preparation of carbacephems |
| 09/01/1993 | EP0558213A1 Process for preparing neotrehalose, and its uses |
| 09/01/1993 | EP0558156A2 Intermediates for 3-aminopiperidine derivates |
| 09/01/1993 | EP0558139A1 Process for preparing fibrinogen receptor antagonists |
| 09/01/1993 | EP0558062A2 Phenoxyacetic acid derivatives and pharmaceutical compositions containing them |
| 09/01/1993 | EP0557939A1 Aldose reductase inhibitor |
| 09/01/1993 | EP0557879A1 4-amino-2-ureido-5-pyrimidincarboxamide, process for their preparation, medicines containing those compounds and their use |
| 09/01/1993 | EP0557877A1 Soluble salts of 4-amino-2-(4,4-dimethyl-imidazolidin-2-on-1-yl)-pyrimidin-5-carboxylic acid N-methyl-N-(3-trifluoromethyl-phenyl)-amide, process for their preparation, their use as medicine and initial products |